BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today reported financial results for the ...

In the early 20th century, a German chemist named Julius Bredt studied double bonds in bicyclic molecules, which are a group ...

Take Bredt's rule for instance, which says stable two-laned connections known as covalent double bonds won't form adjacent to any V-shaped bridges that happen to form across 'bicyclic' molecules.

The agreement is firmly geared towards the back end with an upfront fee of $30 million that gives Roche’s Genentech unit a buy-in to Bicycle’s bicyclic peptide drug discovery platform across a ...

Bicycle Therapeutics has developed a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle) product platform, and will gain funding for phase 1 and phase 1b clinical trial ...